Skip to Main Content

Paper Details

Integrative molecular and functional profiling of ERBB2-amplified breast cancers identifies new genetic dependencies.
Oncogene
24
2014
'triple-negative' breast cancers, +ve, 17q12, ER, ERBB2, ERBB2 gene, ERBB2 oncogene, ERBB2+, ERBB2+ve, ERBB2+ve breast, ERBB2+ve cancers, ERBB2-amplified breast cancers, ERBB2-amplified breast tumour, ERBB2-amplified breast tumour lines, HER2, TFAP2C, amplicons, breast cancers, breast tumour, breast tumour cells, cancer, cancer cells, chromosomes, co-amplified genes, mRNA, receptor tyrosine kinase, transcription factor gene TFAP2C, tyrosine
Author NameAffiliation
Alan MackayThe Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research
Maryou B LambrosThe Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research
Caterina Marchi??University of Turin
Jorge S Reis-FilhoThe Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research
Alan AshworthThe Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research
  • 1 - 5

Datasets

Release 1.2